Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

Pharvaris (PHVS) Institutional Ownership

Pharvaris logo
$29.68 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$29.74 +0.07 (+0.22%)
As of 05/22/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Pharvaris (NASDAQ:PHVS)

Number of
Institutional Buyers
(last 12 months)
72
Total
Institutional Inflows
(last 12 months)
$270.92M
Number of
Institutional Sellers
(last 12 months)
19
Total
Institutional Outflows
(last 12 months)
$115.15M
Get PHVS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Pharvaris stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PHVS Institutional Buying and Selling by Quarter

Pharvaris Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE15,645$442K0.0%-20.0%0.024%
5/19/2026 Stempoint Capital LP86,637$2.45M0.5%+48.4%0.132%
5/18/2026 ADAR1 Capital Management LLC105,528$2.98M0.2%+23.4%0.161%
5/18/2026 Amundi30,952$874K0.0%+12.0%0.047%
5/18/2026 Rock Springs Capital Management LP645,533$18.24M1.1%+3.6%0.987%
5/18/2026 Eversept Partners LP406,960$11.50M0.6%-7.3%0.622%
5/16/2026 The Manufacturers Life Insurance Company 44,195$1.25M0.0%-44.7%0.068%
5/16/2026 SummitTX Capital L.P.29,184$824K0.0%+27.7%0.045%
5/15/2026 Commodore Capital LP1,918,970$54.21M3.1%+1.6%2.934%
5/15/2026 Octagon Capital Advisors LP165,000$4.66M0.5%-75.4%0.252%
2/26/2026 Seven Fleet Capital Management LP55,342$1.54M1.2%N/A0.000%
2/18/2026 XTX Topco Ltd18,568$515K0.0%+126.1%0.000%
2/18/2026 Ikarian Capital LLC486,856$13.51M1.0%+131.7%0.000%
2/18/2026 Virtus Investment Advisers LLC11,011$306K0.1%+66.7%0.000%
2/18/2026 SummitTX Capital L.P.22,859$634K0.0%N/A0.000%
2/18/2026 Tudor Investment Corp ET AL32,028$889K0.0%-58.9%0.000%
2/18/2026 Sphera Funds Management LTD.63,953$1.78M0.3%-46.4%0.000%
2/18/2026 Quadrature Capital Ltd28,920$803K0.0%N/A0.000%
2/18/2026 Occudo Quantitative Strategies LP12,349$343K0.0%N/A0.000%
2/18/2026 Orbimed Advisors LLC205,400$5.70M0.1%N/A0.000%
2/18/2026 Millennium Management LLC248,858$6.91M0.0%+133.6%0.000%
2/18/2026 Elmind Capital LP475,750$13.20M3.9%N/A0.000%
2/18/2026 Eversept Partners LP439,177$12.19M0.6%N/A0.000%
2/18/2026 Commodore Capital LP1,889,445$52.43M3.5%-21.9%0.000%
2/18/2026 Cormorant Asset Management LP1,083,000$30.05M1.4%-20.6%0.000%
2/18/2026 Balyasny Asset Management L.P.496,259$13.77M0.0%-20.7%0.000%
2/18/2026 Boothbay Fund Management LLC157,117$4.36M0.1%+16.2%0.000%
2/17/2026 Logos Global Management LP100,000$2.78M0.2%-33.3%0.000%
2/17/2026 ADAR1 Capital Management LLC85,528$2.37M0.2%+150.6%0.000%
2/17/2026 Bain Capital Life Sciences Investors LLC2,802,081$77.76M6.0%-11.9%0.000%
2/17/2026 Trexquant Investment LP84,353$2.34M0.0%N/A0.000%
2/17/2026 Amundi27,640$767K0.0%-33.4%0.000%
2/17/2026 Jump Financial LLC26,300$730K0.0%N/A0.000%
2/17/2026 Price T Rowe Associates Inc. MD941,605$26.13M0.0%+15.3%0.000%
2/17/2026 Public Employees Retirement System of Ohio7,569$210K0.0%+20.7%0.000%
2/17/2026 California State Teachers Retirement System23,982$666K0.0%+2.2%0.000%
2/17/2026 Polar Capital Holdings Plc237,962$6.60M0.0%-10.1%0.000%
2/16/2026 Squarepoint Ops LLC100,359$2.79M0.0%N/A0.000%
2/16/2026 Sofinnova Investments Inc.745,169$20.68M0.8%+0.7%0.000%
2/16/2026 Verition Fund Management LLC17,898$497K0.0%N/A0.000%
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
2/16/2026 Barclays PLC2,775$77K0.0%N/A0.000%
2/13/2026 Marshall Wace LLP31,832$883K0.0%+17.5%0.000%
2/13/2026 The Manufacturers Life Insurance Company 79,890$2.10M0.0%+33.6%0.000%
2/13/2026 Kalehua Capital Management LLC198,772$5.52M5.1%N/A0.000%
2/13/2026 Schroder Investment Management Group158,019$4.15M0.0%+1,208.9%0.000%
2/13/2026 Birchview Capital LP29,847$828K0.5%+101.0%0.000%
2/13/2026 Police & Firemen s Retirement System of New Jersey8,239$229K0.0%+50.1%0.000%
2/13/2026 State Street Corp161,499$4.48M0.0%+13.1%0.000%
2/13/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC83,947$2.33M0.0%N/A0.000%
2/12/2026 HRT Financial LP14,764$409K0.0%-43.7%0.028%
2/12/2026 Patient Square Capital LP542,696$15.06M3.2%+57.1%1.038%
2/12/2026 Alps Advisors Inc.52,592$1.46M0.0%N/A0.101%
2/12/2026 Swiss National Bank44,757$1.24M0.0%+5.7%0.086%
2/11/2026 Deutsche Bank AG56,388$1.57M0.0%+8.8%0.000%
2/10/2026 TD Asset Management Inc120,248$3.34M0.0%+15.2%0.000%
2/10/2026 Goldman Sachs Group Inc.160,910$4.47M0.0%+1,011.6%0.000%
2/9/2026 Geode Capital Management LLC86,801$2.41M0.0%+10.5%0.166%
2/6/2026 Nano Cap New Millennium Growth Fund L P5,000$139K0.1%N/A0.010%
2/6/2026 PSP Research LLC20,511$569K0.5%N/A0.039%
1/29/2026 UBS Group AG137,734$3.82M0.0%+5.3%0.000%
1/29/2026 China Universal Asset Management Co. Ltd.10,438$290K0.0%+247.9%0.000%
1/27/2026 Zurcher Kantonalbank Zurich Cantonalbank3,979$110K0.0%N/A0.000%
1/27/2026 GF Fund Management CO. LTD.1,258$35K0.0%N/A0.000%
1/26/2026 Mirae Asset Global Investments Co. Ltd.3,113$86K0.0%N/A0.000%
1/21/2026 Palumbo Wealth Management LLC20,182$560K0.1%+21.3%0.000%
1/1/2026 JPMorgan Chase & Co.27,085$676K0.0%+710.4%0.052%
1/1/2026 Tudor Investment Corp ET AL77,891$1.94M0.0%N/A0.149%
12/9/2025 Tudor Investment Corp ET AL77,891$1.94M0.0%N/A0.149%
11/17/2025 Woodline Partners LP100,000$2.50M0.0%N/A0.191%
11/17/2025 venBio Partners LLC4,639,304$115.75M65.6%+8.2%8.872%
11/17/2025 Alyeska Investment Group L.P.125,000$3.12M0.0%N/A0.239%
11/17/2025 VR Adviser LLC674,599$16.83M0.9%-67.1%1.290%
11/17/2025 Polar Capital Holdings Plc264,693$6.60M0.0%N/A0.506%
11/17/2025 Public Employees Retirement System of Ohio6,269$156K0.0%+39.3%0.012%
11/17/2025 Paradigm Biocapital Advisors LP1,835,494$45.80M1.3%+72.7%3.510%
11/17/2025 Novo Holdings A S1,750,000$43.66M2.8%+1.4%3.347%
11/17/2025 Millennium Management LLC106,548$2.66M0.0%+702.0%0.204%
11/17/2025 Foresite Capital Management IV LLC4,778,581$119.23M65.3%+8.3%9.139%
11/17/2025 Citadel Advisors LLC129,738$3.24M0.0%+344.0%0.248%
11/17/2025 Commodore Capital LP2,418,476$60.34M2.9%+26.5%4.625%
11/17/2025 Baker BROS. Advisors LP375,000$9.36M0.1%N/A0.717%
11/17/2025 Bank of America Corp DE18,656$465K0.0%+16.4%0.036%
11/17/2025 Boothbay Fund Management LLC135,181$3.37M0.0%+735.1%0.259%
11/17/2025 Alliancebernstein L.P.8,980$224K0.0%N/A0.017%
11/14/2025 Amundi41,517$965K0.0%+51.4%0.079%
11/14/2025 Deerfield Management Company L.P.2,442,464$60.94M0.9%+21.1%4.671%
11/14/2025 California State Teachers Retirement System23,462$585K0.0%+67.0%0.045%
11/14/2025 Balyasny Asset Management L.P.625,758$15.61M0.0%N/A1.197%
11/14/2025 Two Sigma Investments LP10,607$265K0.0%N/A0.020%
11/14/2025 Integral Health Asset Management LLC200,000$4.99M0.3%N/A0.382%
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
11/14/2025 Wellington Management Group LLP1,734,743$43.28M0.0%N/A3.318%
11/14/2025 General Atlantic L.P.8,031,252$200.38M6.0%+6.6%15.359%
11/13/2025 UBS Group AG130,752$3.26M0.0%+3,393.2%0.250%
11/13/2025 Legal & General Group Plc22,666$566K0.0%+96.2%0.043%
11/13/2025 Schroder Investment Management Group12,073$293K0.0%N/A0.023%
11/10/2025 TD Asset Management Inc104,356$2.60M0.0%+4.9%0.200%
11/10/2025 Palumbo Wealth Management LLC16,641$415K0.1%+14.4%0.032%
11/10/2025 Patient Square Capital LP345,381$8.62M2.3%+41.4%0.661%
11/10/2025 China Universal Asset Management Co. Ltd.3,000$75K0.0%N/A0.006%
11/7/2025 JPMorgan Chase & Co.27,085$676K0.0%+710.4%0.052%


PHVS Institutional Ownership - Frequently Asked Questions

During the previous two years, 88 institutional investors and hedge funds held shares of Pharvaris. The most heavily invested institutionals were General Atlantic L.P. ($200.38M), Foresite Capital Management IV LLC ($119.23M), venBio Partners LLC ($115.75M), FMR LLC ($103.43M), Bain Capital Life Sciences Investors LLC ($77.76M), Deerfield Management Company L.P. ($60.94M), and Commodore Capital LP ($54.21M).Learn more on Pharvaris' institutional investors.

Of the 82 institutional investors that purchased Pharvaris' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wellington Management Group LLP ($1.73M), Paradigm Biocapital Advisors LP ($772.58K), Balyasny Asset Management L.P. ($625.76K), Novo Holdings A S ($581.97K), Patient Square Capital LP ($540.75K), Commodore Capital LP ($536.57K), and General Atlantic L.P. ($500K).

Institutional investors have bought a total of 10,545,067 shares in the last 24 months. This purchase volume represents approximately $270.92M in transactions.

Of the 19 institutional investors that sold Pharvaris' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: VR Adviser LLC ($2.44M), Octagon Capital Advisors LP ($603.69K), Commodore Capital LP ($529.03K), Bain Capital Life Sciences Investors LLC ($379.19K), Cormorant Asset Management LP ($280.20K), Balyasny Asset Management L.P. ($129.50K), and Soleus Capital Management L.P. ($81.68K).

Institutional investors have sold a total of 4,742,046 shares in the last 24 months. This volume of shares sold represents approximately $115.15M in transactions.



This page (NASDAQ:PHVS) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners